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Background: Screening for Hepatitis B and C during pregnancy may help to decide on appropriate antiviral
therapy and the institution of steps to minimize vertical transmission to the newborn infants.
Methods: A cross-sectional study was conducted during November–December 2011 to investigate the
seroprevalence and associated risk factors for markers of HBV (hepatitis B surface antigen; HBsAg) and anti-HCV
antibody among pregnant women at the Al-Thawra hospital in Sana’a, Yemen. Structured questionnaires were used
to obtain sociodemographic obstetrics and medical data and sera were tested for HBsAg and anti-HCV.
Results: Of the 400 pregnant women enrolled in the study, HBsAg and anti-HCV were detected in 43 (10.8%; 95%
CI: 8.0–14.0%) and 34 (8.5%, 95% CI: 6.0–11.5%) women, respectively. None of the women were co-infected with
HBV and HCV. Multivariate analysis showed that circumcision was significantly associated with HBsAg seropositivity
(OR = 3.3, 95% CI: 1.1–10.2; p = 0.03), low parity (primigravidae and secundigravidae) and education below
secondary level were significantly associated with anti- HCV seropositivity (OR = 3.3, 95% CI: 1.1–10.2; p = 0.03). No
other sociodemographic or clinical characteristics (age, residence, history of home delivery, miscarriage, dental
manipulation, surgery, and blood transfusion) were significantly associated with HBsAg or anti-HCV seropositivity.
Conclusion: The results of this study suggest that HBsAg and anti-HCV have high prevalence among pregnant
women.Background
Developing countries have a high incidence of hepatitis B
virus (HBV) and hepatitis C virus (HCV) infections [1,2],
a fact that might partially be explained by non-adherence
to known universal infection control procedures [3].
Women with hepatitis have an increased risk for compli-
cations during pregnancy [4]. In Yemen, previous reports
indicate that hepatitis B is hyperendemic and infection
with HBV and HCV is an important cause of chronic liver
disease [5]. Investigating seroprevalence of hepatitis B sur-
face antigen (HBsAg) and anti-HCV antibody in preg-
nancy in different settings is needed to prevent vertical
transmission. Seroprevalence of these infections among
pregnant women may be a good indicator of general
population prevalence and a determinant of vaccination
policy [6,7]. Pregnancy may be the only clinical access
point for the antenatal population in limited resource set-
tings such as Yemen. Successful interventions to prevent* Correspondence: ishagadam@hotmail.com
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reproduction in any medium, provided the orvertical transmission linked to prenatal and intrapartum
testing have been demonstrated in a variety of limited re-
source settings [8,9]. Although, screening for HBsAg in
pregnancy is recommended by the Royal College of Obste-
tricians and Gynaecologists (United Kingdom), American
Congress of Obstetricians and Gynecologists, as well as
many colleges of obstetrics and gynecology worldwide
[10,11], screening of antenatal women for HBV is not a
routine practice in Yemen. Also, routine vaccination of
newborns is not widely available in Yemen.
Although much recent data are available on the epi-
demiology of HBV and HCV among pregnant women in
different countries [12-16], few published data are avail-
able from Yemen [5]. Such data are fundamental for
health planners and care givers for evidence-based inter-
vention. The current study was conducted at the Al-
Thawra hospital in Sana’a, Yemen to investigate the
seroprevalence and associated risk factors for markers of
HBV (HBsAg) and anti-HCV antibodies among pregnant
women.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Sociodemographic characteristics of pregnant





HBSAg (N = 43)
Women with
anti HCV(34)
Age, years 26.8(5.7) 28.4(6.8) 27.2(6.0)







Rural residence 112(28) 18(42.0) 12(35.3)




Circumcision 22(5.5) 5(11.6) 1(2.9)
Home delivery 73(18.2) 13(30.2) 7(20.6)







*Data are shown as mean (SD) or n (%) as applicable.
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Hospital and patients
This work was conducted as part of Collaboration be-
tween Alzaiem Alazhari University, Khartoum, Sudan and
Al-Thawra Hospital, Sana’a, Yemen in investigating com-
municable diseases during pregnancy [17]. A cross-
sectional study was conducted at the Antenatal Care
Clinic at Al-Thawra Hospital in Sana’a during November–
December 2011. Al-Thawra Hospital is a tertiary care
facility for local women who receive antenatal care at the
hospital as well as for referrals from the other clinics and
hospitals. All women with risk factors or obstetric/medical
complications are referred to the hospital. However, the
referral criteria are not strictly adhered to and many
women without any significant complications are allowed
to deliver at the hospital. After giving signed informed
consent, women with a singleton baby were approached
to participate in the study. Those with antepartum
hemorrhage, hypertension and diabetes mellitus were ex-
cluded. A fixed questionnaire was applied to gather rele-
vant sociodemographic characteristics (age, education and
residence) and obstetric characteristics (gestational age
and parity). Then the possible risk factors (e.g. history of
surgery or blood transfusion, tattooing, and circumcision)
for HBV were investigated. After centrifugation, serum
samples were tested for HBsAg and anti-HCV using an
ELISA (4th generation).
Statistics
A sample size of 400 patients was calculated based on a
two-sided hypothesis test using Epiinfo with 80% power
and 95% CI. Statistical analysis was performed using SPSS
for Windows version 16.0 (SPSS Inc., Chicago, IL, USA)
and all data were double-checked before analysis. The
mean and proportion of the sociodemographic and clinical
characteristics were calculated for the HBsAg and anti-
HCV seropositive groups. Univariate and multivariate ana-
lyses were performed using seropositivity for HBsAg and
anti-HCV as dependent variables and sociodemographic
and clinical variables (age, residence, parity, circumcision,
education, history of surgery, miscarriage, blood trans-
fusion dental manipulation and traditional scar), as in-
dependent variables. A p value < 0.05 was considered
significant.
Ethics
Ethical approval was obtained from the Ethics Review
Committee at Alzaiem Alazhari University, Sudan and at
Al-Thawra Hospital, Sana’a, Yemen.
Results
General characteristics
Four hundred pregnant women were enrolled with a
mean (SD) age of 26.8 (5.7) years. Seventy-nine and 77of these pregnant women were primigravidae and
secundigravidae, respectively. Around half (49.2%) of the
women had educational level below secondary school
(<9 years) and 197 (49.2%) were rural residents. None of
the women were immunized against HBV. The
sociodemographic details and clinical characteristics are
shown in Table 1.
HBsAg and anti-HCV seroprevalence
Among the 400 pregnant women enrolled in the study,
HBsAg and anti-HCV was detected in 43 (10.8%; 95%
CI: 8.0–14.0%) and 34 (8.5%, 95% CI: 6.0–11.5%), re-
spectively. None of the patients were infected by both
HBV and HCV.
Risk factors for HBsAg or anti-HCV
Although multivariate analysis showed that circumcision
was significantly associated with HBsAg seropositivity
(OR = 3.3, 95% CI: 1.1–10.2; p = 0.03), age, gravidity and
rural residency were significantly associated with HBsAg
seropositivity in univariate analysis only. No other
sociodemographic or clinical characteristics (history of
home delivery, miscarriage, dental manipulation, surgery,
traditional scar and blood transfusion) were significantly
associated with HBsAg (Table 2).
In multivariate analysis, low parity (primigravidae and
secundigravidae) (OR = 2.9, 95% CI: 1.1–8.4; p = 0.03)
and education below secondary level (OR = 2.9, 95% CI:
1.2–7.0; p = 0.031) were significantly associated with
Table 2 Univariate and multivariate analyses for possible risk factors for HBsAg among pregnant women in Yemen
The variables Univariate analysis Multivariate analysis
O R 95% CI P O R 95% CI P
Age 0.9 0.8–0.9 0.04 0.9 0.9–1.0 0.9
Gravidity 0.8 0.8–0.9 0.03 0.9 0.7–1.1 0.6
Education < secondary school 0.6 0.3–1.1 0.1 1.0 0.6–1.5 0.9
Rural residence 2.0 1.1–3.5 0.03 1.9 0.9–3.9 0.06
Blood transfusion 1.1 0.6–2.6 0.6 1.0 0.6–1.5 0.9
Surgical operation 1.2 0.6–2.3 0.4 1.1 0.6–1.9 0.5
Circumcision 2.6 0.9–7.5 0.07 3.3 1.1–10.2 0.03
Home delivery 2.1 1.1–1.9 4.3 1.6 0.6–4.1 0.2
Traditional scar 1.3 0.6–2.8 0.3 1.0 0.6–1.7 0.7
Dental manipulation 1.6 0.7–3.8 0.2 1.4 0.5–3.4 0.4
History of miscarriage 1.3 0.7–2.5 0.3 0.9 0.4–2.1 0.8
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0.03). History of blood transfusion, surgical operation,
and traditional scarring were significantly associated
with anti- HCV seropositivity in univariate analysis only.
Other sociodemographic or clinical characteristics (age,
residence, history of home delivery, miscarriage, circum-
cision, dental manipulation) were not significantly asso-
ciated with anti-HCV seropositivity (Table 3).Discussion
These are believed to be the first published data on HBsAg
and anti-HCV among pregnant women in Yemen. The
main finding of the study was the high prevalence of
HBsAg and anti-HCV (10.8% and 8.5%) among pregnant
women in this setting. The prevalence of HBsAg and anti-
HCV among these pregnant women was higher than the
prevalence of these markers among healthcare workers inTable 3 Univariate and multivariate analyses for possible risk
The variables Univariate analy
O R 95% CI
Age 0.9 0.9–1.0
Primigravidae and secundigravidae 2.6 1.1–6.2
Education < secondary school 1.8 0.9–3.8
Rural residence 1.4 0.6–3.0
Blood transfusion 2.9 1.4–6.1
Surgical operation 2.7 1.3–5.5
Circumcision 0.4 0.6–3.8
Home delivery 1.1 0.5–2.8
Traditional scar 2.2 1.1–4.8
Dental manipulation 1.4 0.5–3.6
History of miscarriage 1.7 0.8–3.4large hospitals in Sana’a [54/543 (9.9%) and 19/546 (3.5%)]
[18], Ibb (1.81% and 1.99%) [19], and Aden [20].
Recent reports have documented a lower prevalence of
HBsAg and anti-HCV among pregnant women in differ-
ent countries; for example, 4.0% and 6.4% in Egypt [12],
4.6% and 7.0% in Pakistan [13], 2.8% and 0.1% in Turkey
[14], 1.53% and 0.31% in Afghanistan [15], and 5.6% and
0.3% in Sudan [16]. A finding similar to that by Elsheikh
et al., in this study is that none of the patients were
infected by both HBV and HCV [16].
The current study showed that circumcision was sig-
nificantly associated with HBsAg seropositivity, and low
parity and lower education levels were significantly asso-
ciated with anti-HCV seropositivity. Female circumci-
sion, which is usually performed at home by midwives
or health workers at young ages, might be the source of
infection in these women. Recently, it has been observed
that previous history of surgery, multiple injectionfactors for anti-HCV among pregnant women in Yemen
sis Multivariate analysis
P O R 95% CI P
0.6 1.0 0.9–1.1 0.5
0.02 2.9 1.1–8.4 0.03
0.09 2.9 1.2–7.0 0.01
0.3 1.6 0.7–3.8 0.2
0.01 2.0 0.8–4.8 0.1
0.01 1.6 0.6–4.0 0.2
0.5 0.4 0.5–3.9 0.4
0.6 1.1 0.4–3.1 0.7
0.03 1.0 0.6–1.4 0.9
0.4 1.2 0.4–3.4 0.6
0.1 1.2 0.5–2.8 0.5
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anti-HCV and HBsAg-positive pregnant women [14],
and high parity, older age and blood transfusion were in-
dependently associated with HCV among pregnant
women [21,22]. However, none of the known risk factors
was found to be significantly associated with the HCV
infection among pregnant Indian women [23]. Other risk
factors such as early age of sexual debut, history of mul-
tiple sexual partners, and past history of sexually trans-
mitted infection were found to be significantly
associated with HBV among pregnant women [24]. As a
result of social and religious reasons, these factors are
difficult to be investigated in Yemen. Perhaps if these
risk factors were investigated, different results might
have been obtained.
In spite of high prevalence of HBsAg and HCV in the
current study, some points need to be mentioned. The
population investigated consisted only of women able to
access antenatal care, and the prevalence reported here
may have underestimated the true prevalence among
pregnant women in the community. Furthermore, these
women presented to a tertiary hospital, therefore, they
cannot represent Yemen as a whole. The prevalence is
high when compared to the general population and this
might be explained by the population being over-
represented. As mentioned above, there may have been
under-reporting of risky behaviors or other socially un-
desirable responses in this survey. The majority of the
mothers were from low socioeconomic backgrounds;
therefore, it is difficult to suggest that the infection was
more prevalent in those with a lower educational level.
These women were not screened for hepatitis D virus,
HIV and other sexually transmitted diseases, and their
partners were not screened for HBV and HCV. Unfortu-
nately it was difficult to follow-up these women till de-
livery to establish vertical transmission and its associated
factors.Conclusions
The results of this study suggest that HBsAg and anti-
HCV have high prevalence among pregnant women. Cir-
cumcision was a risk factor for HBsAg, and low parity and
lower education levels were risk factors for anti-HCV.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
EAM, SMB and IA were involved in study conception and design. DAR and
GIG were involved in acquisition, analysis and interpretation of data. All the
authors were involved in drafting the manuscript and its critical revision. All
authors read and approved the final manuscript.
Author details
1Department of Obstetrics and Gynecology, AL Kuwait hospital, Sana’a,
Yemen. 2Faculty of Medicine, Alzaiem Alazhari University, Khartoum North,Sudan. 3Faculty of Medicine, University of Khartoum, P O Box102, Khartoum,
Sudan.
Received: 4 January 2013 Accepted: 5 June 2013
Published: 7 June 2013
References
1. Madhava V, Burgess C, Drucker E: Epidemiology of chronic hepatitis C
virus infection in sub-Saharan Africa. Lancet Infect Dis 2002, 2:293–302.
2. Jobarteh M, Malfroy M, Peterson I, Jeng A, Sarge-Njie R, Alabi A, Peterson K,
Cotten M, Hall A, Rowland-Jones S, Whittle H, Tedder R, Jaye A, Mendy M:
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected
Gambians. Virol J 2010, 15(7):230.
3. Telaku S, Fejza H, Elezi Y, Bicaj T: Hepatitis B and C in dialysis units in
Kosova. Virol J 2009, 4(6):72.
4. Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK: Pregnancy
outcomes associated with viral hepatitis. J Viral Hepat 2011, 18:e394–e398.
5. El Guneid AM, Gunaid AA, O’Neill AM, Zureikat NI, Coleman JC,
Murray-Lyon IM: Prevalence of hepatitis B, C, and D virus markers in
Yemeni patients with chronic liver disease. J Med Virol 1993, 40:330–333.
6. Saphonn V, Hor LB, Ly SP, Chhuon S, Saidel T, Detels R: How well do
antenatal clinic (ANC) attendees represent the general population?
A comparison of HIV prevalence from ANC sentinel surveillance sites
with a population-based survey of women aged 15–49 in Cambodia.
Int J Epidemiol 2002, 31:449–455.
7. Fabiani M, Fylkesnes K, Nattabi B, Ayella EO, Declich S: Evaluating two
adjustment methods to extrapolate HIV prevalence from pregnant
women to the general female population in sub-Saharan Africa.
AIDS 2003, 17:399–405.
8. Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ,
Poerschke G: Protective efficacy of hepatitis B vaccine without HBIG in
infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002,
20:3739–3743.
9. Department of Vaccines and Biologicals, World Health Organization:
Introduction of hepatitis B vaccine into childhood immunization services.
Management guidelines, including information for health workers and parents.
Geneva: World Health Organization; 2001.
10. National Institute for Health and Clinical Excellence (NICE): Ante-natal care.
Routine care for healthy pregnant women. National Collaborating Center
for Women’s and Children’s Health 2008, 62:1–454.
11. American College of Obstetricians and Gynecologists (ACOG): Viral hepatitis
in pregnancy. Washington DC: ACOG Practice Bulletin ACOG; 2007:86.
12. Zahran KM, Badary MS, Agban MN, Abdel Aziz NH: Pattern of hepatitis
virus infection among pregnant women and their newborns at the
Women’s health center of Assiut University, upper Egypt. Int J Gynaecol
Obstet 2010, 111:171–174.
13. Taseer IU, Ishaq F, Hussain L, Safdar S, Mirbahar AM, Faiz SA: Frequency of
anti-HCV, HBsAg and related risk factors in pregnant women at Nishtar
Hospital, Multan. J Ayub Med Coll Abbottabad 2010, 22:13–16.
14. Altinbas S, Erdogan M, Danişman N: The seroprevalences of HBs Ag and
anti-HCV in pregnant women in Ankara. Arch Gynecol Obstet 2010,
281:371.
15. Todd CS, Ahmadzai M, Atiqzai F, Miller S, Smith JM, Ghazanfar SA, Strathdee
SA: Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C
virus among intrapartum patients in Kabul Afghanistan. BMC Infect Dis
2008, 8:119.
16. Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I: Hepatitis B virus
and hepatitis C virus in pregnant Sudanese women. Virol J 2007, 4:104.
17. Albiti AH, Adam I, Ghouth AS: Placental malaria, anemia and low birth
weight in Yemen. Trans R Soc Trop Med Hyg 2010, 104:191–194.
18. Shidrawi R, Ali Al-Huraibi M, Ahmad Al-Haimi M, Dayton R, Murray-Lyon IM:
Seroprevalence of markers of viral hepatitis in Yemeni healthcare
workers. J Med Virol 2004, 73:562–565.
19. Gacche RN, Kaid AM: Epidemiology of viral hepatitis B and C infections in
Ibb city, Yemen. Hepat Mon 2012, 12:460–462.
20. Bawazir AA, Parry CM, Hart CA, Sallam TA, Beeching N, Cuevas LE:
Seroepidemiology and risk factors of hepatitis B virus in Aden, Yemen.
J Infect Public Health 2011, 4:48–54.
21. Khan UR, Janjua NZ, Akhtar S, Hatcher J: Case–control study of risk factors
associated with hepatitis C virus infection among pregnant women in
hospitals of Karachi-Pakistan. Trop Med Int Health 2008, 13:754–61.
Murad et al. BMC Pregnancy and Childbirth 2013, 13:127 Page 5 of 5
http://www.biomedcentral.com/1471-2393/13/12722. AbdulQawi K, Youssef A, Metwally MA, Ragih I, AbdulHamid M, Shaheen A:
Prospective study of prevalence and risk factors for hepatitis C in
pregnant Egyptian women and its transmission to their infants. Croat
Med J 2010, 51:219–228.
23. Kumar A, Sharma KA, Gupta RK, Kar P, Chakravarti A: Prevalence & risk
factors for hepatitis C virus among pregnant women. Indian J Med Res
2007, 126(3):211–215.
24. Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO: Risk factors for
hepatitis B virus infection among pregnant women in Lagos, Nigeria.
Acta Obstet Gynecol Scand 2010, 89:1024–1028.
doi:10.1186/1471-2393-13-127
Cite this article as: Murad et al.: Epidemiology of hepatitis B and
hepatitis C virus infections in pregnant women in Sana’a, Yemen. BMC
Pregnancy and Childbirth 2013 13:127.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
